Literature DB >> 15186020

Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.

Mehmet Erdem1, Ahmet Erdem, Rifat Gursoy, Kutay Biberoglu.   

Abstract

PURPOSE: To compare basal and clomiphene citrate (CC) induced follicle-stimulating hormone (FSH), estradiol (E2), and inhibin B levels with ultrasound indices of ovarian reserve in infertile women and to test the prognostic value of these tests on response to ovarian stimulation in in vitro fertilization (IVF).
METHODS: Fifty-six patients had basal and CC induced serum hormone levels and ultrasound measured mean ovarian volume (MOV) and mean antral follicle counts (MFC). Thirty-two patients were then appropriately selected to have a total of 41 cycles of IVF/ICSI treatment.
RESULTS: Women with diminished ovarian reserve had lower MOV, MFC, day 3 and day 10 inhibin B levels (p < 0.001). Only basal and CC induced FSH and inhibin B correlated with MOV and MFC. Poor responders in IVF/ICSI had higher basal FSH (p < 0.05), lower basal and induced inhibin B levels (p < 0.05), and lower MOV and MFC (p < 0.01) than normal responders. Ovarian volume alone was better than age and basal hormones in predicting poor ovarian response, while abnormal CC test was the only independent significant factor in predicting ovarian response. However, age was the only independent predictor of pregnancy in IVF as compared to hormonal and ultrasound indices of ovarian reserve.
CONCLUSION: CC test and ovarian volume are better than other hormonal and sonographic tests in predicting the response to ovarian stimulation in IVF cycles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186020      PMCID: PMC3455448          DOI: 10.1023/b:jarg.0000025936.73125.b4

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  34 in total

1.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

2.  Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization.

Authors:  L F Bancsi; A M Huijs; C T den Ouden; F J Broekmans; C W Looman; M A Blankenstein; E R te Velde
Journal:  Fertil Steril       Date:  2000-03       Impact factor: 7.329

3.  Inhibin-B as a test of ovarian reserve for infertile women.

Authors:  S L Corson; J Gutmann; F R Batzer; H Wallace; N Klein; M R Soules
Journal:  Hum Reprod       Date:  1999-11       Impact factor: 6.918

4.  Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization.

Authors:  R T Scott; G E Hofmann; S Oehninger; S J Muasher
Journal:  Fertil Steril       Date:  1990-08       Impact factor: 7.329

5.  Age and the ovarian follicle pool assessed with transvaginal ultrasonography.

Authors:  M L Ruess; J Kline; R Santos; B Levin; I Timor-Tritsch
Journal:  Am J Obstet Gynecol       Date:  1996-02       Impact factor: 8.661

6.  Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels.

Authors:  T Tanbo; P O Dale; O Lunde; N Norman; T Abyholm
Journal:  Fertil Steril       Date:  1992-04       Impact factor: 7.329

Review 7.  Prognostic assessment of ovarian reserve.

Authors:  R T Scott; G E Hofmann
Journal:  Fertil Steril       Date:  1995-01       Impact factor: 7.329

8.  Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age.

Authors:  R T Scott; M S Opsahl; M R Leonardi; G S Neall; E H Illions; D Navot
Journal:  Hum Reprod       Date:  1995-07       Impact factor: 6.918

9.  Ovarian volume: a novel outcome predictor for assisted reproduction.

Authors:  C H Syrop; A Willhoite; B J Van Voorhis
Journal:  Fertil Steril       Date:  1995-12       Impact factor: 7.329

10.  Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization.

Authors:  F L Licciardi; H C Liu; Z Rosenwaks
Journal:  Fertil Steril       Date:  1995-11       Impact factor: 7.329

View more
  8 in total

1.  The Predictive Levels of Serum Anti-Müllerian Hormone and the Combined Index of the Number of Retrieved Oocytes and Good-Quality Embryos in Advanced-Age Infertile Women.

Authors:  Tie-Cheng Sun; Xi Chen; Cheng Shi; Li Tian; Shan-Jie Zhou
Journal:  Int J Endocrinol       Date:  2022-04-18       Impact factor: 2.803

Review 2.  A new approach to ovarian reserve testing.

Authors:  Wenjie Sun; Barbara J Stegmann; Melinda Henne; William H Catherino; James H Segars
Journal:  Fertil Steril       Date:  2008-04-22       Impact factor: 7.329

3.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

4.  Ovarian reserve tests.

Authors:  Padma Rekah Jirge
Journal:  J Hum Reprod Sci       Date:  2011-09

Review 5.  Clinical application of serum anti-Müllerian hormone in women.

Authors:  So Ra Oh; Sun Yi Choe; Yeon Jean Cho
Journal:  Clin Exp Reprod Med       Date:  2019-06-01

6.  High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment.

Authors:  Tie-Cheng Sun; Shan-Jie Zhou; Ling-Li Song; Jian-Hua Li; Xi Chen; Li Tian
Journal:  JBRA Assist Reprod       Date:  2021-04-27

7.  Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?

Authors:  Jingyi Wen; Kecheng Huang; Xiaofang Du; Hanwang Zhang; Ting Ding; Cuilian Zhang; Wenmin Ma; Ying Zhong; Wenyu Qu; Yi Liu; Zhiying Li; Song Deng; Aiyue Luo; Yan Jin; Jinjin Zhang; Shixuan Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-14       Impact factor: 5.555

8.  Bushen Culuan Decoction Ameliorates Premature Ovarian Insufficiency by Acting on the Nrf2/ARE Signaling Pathway to Alleviate Oxidative Stress.

Authors:  Yanxia Chen; Xiaodi Fan; Kun Ma; Kaili Wang; Caidie Tian; Min Li; Linjuan Gong
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.